Mark Lebovitch Featured in New York Times Coverage of Pfizer Litigation
December 6, 2010
The New York Times interviewed BLB&G partner Mark Lebovitch in its coverage of the recent settlement obtained by the firm in its derivative shareholder litigation against Pfizer, Inc.
Representing BLB&G client the Louisiana Sheriffs' Pension and Relief Fund, the suit alleges, among other things, that the Board and top officials at the company failed to stop illegal drug marketing practices. Mr. Lebovitch explains that the "core question of the case was, where was the board when this was going on?"
In what Mr. Lebovitch describes as "one of the largest derivative settlements ever and a good outcome for shareholders," Pfizer agreed to set aside $75 million to fund a Regulatory and Compliance Committee, which not only materially enhances the Pfizer board's oversight but may set a new benchmark of good corporate governance for all highly regulated companies.
Mr. Lebovitch is primarily responsible for the firm's corporate governance litigation practice, focusing on derivative suits and transactional litigation. He has served as one of the lead counsel in many of the most significant corporate governance actions in the past five years, and is currently serving as a co-lead counsel prosecuting challenges to a management buyout of J. Crew, a private equity buyout of Novell, and derivative suits alleging bad faith conduct by the boards of Johnson & Johnson, BP, plc, and Massey Corporation.
Also of Interest
Benchmark Names Mark Lebovitch One of the Nation’s Top 10 Securities Lawyers
Law360 Names Mark Lebovitch a “Titan of the Plaintiffs Bar”
May 7, 2018
20 BLB&G Attorneys Named by Super Lawyers to its 2018 New York Metro Edition
BLB&G’s Mark Lebovitch Selected an Adviser on ALI’s “Restatement of the Law, Corporate Governance” Project
April 1, 2019
The National Law Journal Names Mark Lebovitch and Jeroen van Kwawegen 2018 Plaintiffs’ Lawyers Trailblazers
Benchmark Names BLB&G Top Plaintiff Firm in the Nation for the Third Time
February 17, 2017
Benchmark Names Eight BLB&G Partners as Litigation Stars
Benchmark Once Again Names Seven BLB&G “Litigation Stars”
Super Lawyers Names 21 BLB&G Attorneys to its 2017 New York Metro Edition
September 20, 2017
Super Lawyers Names 20 BLB&G Attorneys to its 2016 New York Metro Edition